OLPX

$1.33+0.03 (+2.31%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Olaplex Holdings, Inc., through its subsidiaries, develops, manufactures, and sells haircare products in the United States and internationally.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

AMZNTSLAHD

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.33
Potential Upside
5%
Whystock Fair Value$1.40
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorConsumer Cyclical
IndustrySpecialty Retail

Olaplex Holdings, Inc., through its subsidiaries, develops, manufactures, and sells haircare products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection o...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$890.31M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.24
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-0.15%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
4.00

Recent News

Simply Wall St.
Mar 20, 2026

Why The Olaplex (OLPX) Story Is Shifting As Analysts Reset Expectations And Targets

The Street’s average price target for Olaplex Holdings has shifted from US$4.00 to US$2.50, with one fair value estimate moving slightly from US$1.92 to US$1.85, signaling a reset in what analysts see as a reasonable central case. This US$2.50 level lines up with an In Line stance, reflecting a split between those who see room for execution upside and those more focused on growth and valuation constraints. Read on to see how to track this evolving narrative and what it can mean for your own...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Mar 20, 2026

Morgan Stanley Reiterates Olaplex Holdings (OLPX) With a Hold Rating

Olaplex Holdings, Inc. (NASDAQ:OLPX) is one of the High-Flying Penny Stocks to Buy. On March 10, Morgan Stanley reiterated an Equalweight rating on the stock with a price target of $1.40. The rating follows the company’s fiscal Q4 2025 earnings, which were reported on March 5, 2025. ​Olaplex Holdings, Inc. (NASDAQ:OLPX) grew its quarterly revenue […]

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
StockStory
Mar 12, 2026

The Top 5 Analyst Questions From Olaplex’s Q4 Earnings Call

Olaplex’s fourth quarter was marked by year-on-year revenue growth, driven primarily by improved sell-through in the professional and direct-to-consumer channels and a refreshed brand identity. However, the market responded negatively to the results, reflecting investor concerns about the company’s declining operating margin and the lingering effects of recent channel realignment. CEO Amanda Baldwin highlighted a "comprehensive new visual identity supported by a 360-degree marketing engine" and

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 9, 2026

3 Profitable Stocks Walking a Fine Line

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Mar 8, 2026

Olaplex (OLPX) Q4 2025 Revenue Grows 4% to $105.1M Despite EPS Miss

Olaplex Holdings Inc. (NASDAQ:OLPX) is one of the best new penny stocks to buy. On March 5, Olaplex Holdings reported its Q4 2025 financial results, beating earnings expectations with an adjusted EPS of $0.01. The company stabilized its net sales for the full-year 2025 at $423 million, ending a period of declines in previous years. […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.